Basal Cell Carcinoma
- PMID: 29494046
- Bookshelf ID: NBK482439
Basal Cell Carcinoma
Excerpt
Basal cell carcinoma (BCC), previously known as basal cell epithelioma, is the most common cancer in Humans. BCC mostly arises on sun-damaged skin and rarely develops on the mucous membranes or palms and soles. Basal cell carcinoma is usually a slow-growing tumor for which metastases are rare. Although rarely fatal, BCC can be highly destructive and disfigure local tissues when treatment is inadequate or delayed. On clinical examination, BCC usually appears as flesh- or pink-colored, pearly papules with overlying ulceration or telangiectatic vessels. BCC occurs on the head or neck in the majority of cases, but can involve the trunk and extremities.
More than 26 different subtypes of BCC appear in the literature, but the more common, distinctive, clinicopathologic types include: nodular, micronodular, superficial, morpheaform, infiltrative and fibroepithelial (also known as fibroepithelioma of Pinkus). Combinations of these types can occur as well. The majority of BCCs are amelanotic, but variable amounts of melanin may be present within these tumors.
The current mainstay of BCC treatment involves surgical modalities such as excision, electrodesiccation and curettage (EDC), cryosurgery, and Mohs micrographic surgery. Such methods are typically reserved for localized BCC and offer high 5-year cure rates, generally over 95%.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
Similar articles
-
Dermoscopy of Basal Cell Carcinoma Part 2: Dermoscopic Findings by Lesion Subtype, Location, Age of Onset, Size and Patient Phototype.Cancers (Basel). 2025 Jan 8;17(2):176. doi: 10.3390/cancers17020176. Cancers (Basel). 2025. PMID: 39857958 Free PMC article. Review.
-
Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.Dermatol Surg. 2013 May;39(5):719-25. doi: 10.1111/dsu.12122. Epub 2013 Feb 4. Dermatol Surg. 2013. PMID: 23379543
-
Diagnosis and Management of Basal Cell Carcinoma.Curr Treat Options Oncol. 2019 Feb 11;20(2):13. doi: 10.1007/s11864-019-0610-0. Curr Treat Options Oncol. 2019. PMID: 30741348 Review.
-
Subclinical infiltration of Basal cell carcinoma in asian patients: assessment after mohs micrographic surgery.Ann Dermatol. 2011 Aug;23(3):276-81. doi: 10.5021/ad.2011.23.3.276. Epub 2011 Aug 6. Ann Dermatol. 2011. PMID: 21909195 Free PMC article.
-
Variations in clinical presentation of basal cell carcinoma.Acta Clin Croat. 2008 Mar;47(1):25-30. Acta Clin Croat. 2008. PMID: 18714644 Review.
References
-
- De Giorgi V, Savarese I, Gori A, Scarfi F, Topa A, Trane L, Portelli F, Innocenti A, Covarelli P. Advanced basal cell carcinoma: when a good drug is not enough. J Dermatolog Treat. 2020 Sep;31(6):552-553. - PubMed
-
- Kamath P, Darwin E, Arora H, Nouri K. A Review on Imiquimod Therapy and Discussion on Optimal Management of Basal Cell Carcinomas. Clin Drug Investig. 2018 Oct;38(10):883-899. - PubMed
-
- Martens MC, Seebode C, Lehmann J, Emmert S. Photocarcinogenesis and Skin Cancer Prevention Strategies: An Update. Anticancer Res. 2018 Feb;38(2):1153-1158. - PubMed
Publication types
LinkOut - more resources
Full Text Sources